Tuberculosis (TB) was declared a national emergency in Mozambique in March 2006. APOPO supports the country’s Ministry of Health TB control program. Our integrated TB detection approach in Maputo helps identifying additional TB cases by collecting and re-evaluating patient sputum samples from partner clinics and or providing molecular testing services. Results are returned within 24 hours so that newly diagnosed patients can start treatment early.
APOPO refurbished and equipped a TB detection rat facility in partnership with the Veterinary School of the Eduardo Mondlane University in Maputo in 2012. The facility is situated on the University grounds and has been operational since 2013. It expanded further in early 2018, now using two 16-module GeneXpert machine for rapid molecular diagnostic of TB offering a testing capacity of 96 samples a day. This investment was crucial to align with the country’s efforts to roll out molecular testing as the first diagnostic tool for TB. APOPO has progressively began providing more molecular testing services.
Ariound 17 health centers in Maputo city are now collaborating with the project by providing sputum samples from patients with presumptive TB. The confirmed additional positive results are then communicated back to the health centers and to partner organization CCS (Centro para Colaboração em Saúde) and its contracted community-based associations, allowing their community health workers to trace the patients back and get them on treatment.
APOPO in Mozambique
Home » What we do » Detecting Tuberculosis » Where we work » APOPO in Mozambique
Active

As one of the 30 high TB-burden countries, raising the clinic detection rate of tuberculosis and ensuring all TB-positive patients receive treatment is our main goal. We also recognize that our testing capacity can help in response to other health issues and we aim to make the best use of it to support the Mozambican health system and our partners.

Robert Burny, Program Manager
APOPO TB MOZAMBIQUE
APOPO in Mozambique PARTNERS AND DONORS










